CAPITAL ACCESS AGREEMENTCapital Access Agreement • June 13th, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CAPITAL ACCESS AGREEMENT (the “Agreement”), is dated as of June 10, 2016, by and between Immune Pharmaceuticals Inc., a Delaware corporation, (the “Company”), and Regatta Select Healthcare, LLC, a Delaware limited liability company (including any designee(s) thereof, the “Investor”).
AMENDMENT NO. 1 TO CAPITAL ACCESS AGREEMENTCapital Access Agreement • June 13th, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 to the Capital Access Agreement dated June 10, 2016 (this “Amendment”), between Immune Pharmaceuticals Inc., a Delaware corporation having its principal place of business at 430 East 29th Street, Suite 940, New York, NY 10016 (“Immune”), and Regatta Select Healthcare LLC, a Delaware limited liability company, having its principal place of business at 18 Lafayette Place, New York, NY 10017 (“Regatta), and together with Immune, the “Parties,” and each, a “Party”).
